These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 15919764

  • 1. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
    Fortin JP, Gera L, Bouthillier J, Stewart JM, Adam A, Marceau F.
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
    [Abstract] [Full Text] [Related]

  • 2. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
    Gera L, Fortin JP, Adam A, Stewart JM, Marceau F.
    J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
    [Abstract] [Full Text] [Related]

  • 3. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
    Bawolak MT, Gera L, Morissette G, Bouthillier J, Stewart JM, Gobeil LA, Lodge R, Adam A, Marceau F.
    J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
    [Abstract] [Full Text] [Related]

  • 4. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
    Drapeau G, Audet R, Levesque L, Godin D, Marceau F.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
    [Abstract] [Full Text] [Related]

  • 5. Non-competitive pharmacological antagonism at the rabbit B(1) receptor.
    Larrivée JF, Gera L, Houle S, Bouthillier J, Bachvarov DR, Stewart JM, Marceau F.
    Br J Pharmacol; 2000 Nov; 131(5):885-92. PubMed ID: 11053207
    [Abstract] [Full Text] [Related]

  • 6. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G, deBlois D, Marceau F.
    J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
    [Abstract] [Full Text] [Related]

  • 7. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S, Quartara L, Rizzi A, Patacchini R, Cucchi P, Giolitti A, Calò G, Regoli D, Criscuoli M, Maggi CA.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [Abstract] [Full Text] [Related]

  • 8. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
    Bawolak MT, Fortin JP, Vogel LK, Adam A, Marceau F.
    Eur J Pharmacol; 2006 Dec 03; 551(1-3):108-11. PubMed ID: 17026984
    [Abstract] [Full Text] [Related]

  • 9. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor.
    Morissette G, Fortin JP, Otis S, Bouthillier J, Marceau F.
    J Pharmacol Exp Ther; 2004 Dec 03; 311(3):1121-30. PubMed ID: 15277582
    [Abstract] [Full Text] [Related]

  • 10. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT, Gera L, Morissette G, Stewart JM, Marceau F.
    J Pharmacol Exp Ther; 2007 Nov 03; 323(2):534-46. PubMed ID: 17699739
    [Abstract] [Full Text] [Related]

  • 11. Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery.
    Pelorosso FG, Brodsky PT, Zold CL, Rothlin RP.
    J Pharmacol Exp Ther; 2005 Jun 03; 313(3):1355-60. PubMed ID: 15764737
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S, Lecci A, Cucchi P, Catalioto RM, Criscuoli M, Maggi CA.
    J Pharmacol Exp Ther; 1998 Oct 03; 287(1):137-43. PubMed ID: 9765332
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS, Marathe MV, Kuhlman KG, Fitzpatrick TD, Cuadrado D, Hanson W, Zuzack JS, Ross SE, Wieczorek M, Burkard M, Whalley ET.
    J Med Chem; 1996 Mar 29; 39(7):1472-84. PubMed ID: 8691478
    [Abstract] [Full Text] [Related]

  • 16. Effect of allelic polymorphism of the B(1) and B(2) receptor genes on the contractile responses of the human umbilical vein to kinins.
    Houle S, Landry M, Audet R, Bouthillier J, Bachvarov DR, Marceau F.
    J Pharmacol Exp Ther; 2000 Jul 29; 294(1):45-51. PubMed ID: 10871294
    [Abstract] [Full Text] [Related]

  • 17. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
    Santos EL, de Picoli Souza K, Cibrián-Uhalte E, Oliveira SM, Bader M, Costa-Neto CM, Oliveira L, Pesquero JB.
    Int Immunopharmacol; 2008 Feb 29; 8(2):282-8. PubMed ID: 18182241
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.